Company Filing History:
1 out of 1,933 
1 out of 894 
Years Active: 2021
Title: Innovations of Eleni Markousta: A Pioneer in Ocular Drug Delivery
Introduction
Eleni Markousta, an accomplished inventor based in Tampa, FL, has made significant strides in the field of ocular medicine. With her innovative approach to drug delivery, she has worked on groundbreaking technology aimed at treating diseases of the posterior segment of the eye.
Latest Patents
Eleni is the holder of a patent titled "Method of delivering genes and drugs to a posterior segment of an eye." This invention features a multifunctional dendrimer nanoparticle that enables effective and non-invasive treatment of various diseases affecting the posterior segment of the eye. The patent highlights how functionalized polyamidoamine (PAMAM) dendrimers can efficiently deliver drugs and/or genes, enhancing the efficacy of treatments through a topical application. Notably, the multifunctional dendrimer nanoparticle incorporates shRNA-encoding DNA alongside a small molecule drug encapsulated in a cyclodextrin complex, facilitating targeted delivery and improved therapeutic outcomes.
Career Highlights
Eleni Markousta's career has been distinguished by her engagement with reputable institutions. She has contributed to the University of South Florida and has collaborated with The United States Government as represented by the Department of Veterans Affairs. Her work in these esteemed organizations has allowed her to refine her expertise in the realms of biomedical engineering and pharmacology, driving forward her innovative projects.
Collaborations
Throughout her innovative journey, Eleni has collaborated with notable colleagues, including Shyam S Mohapatra and Subhra Mohapatra. Together, they have worked on advancing research and exploring new frontiers in ocular drug delivery, fostering a collaborative spirit that is essential in such a rapidly evolving field.
Conclusion
Eleni Markousta's contributions to ocular medicine exemplify the importance of innovation in enhancing treatment options for patients. Her groundbreaking patent on a multifunctional dendrimer nanoparticle showcases a significant advancement in the delivery of therapeutics to the eye. As her career progresses, she continues to be a vital force within the scientific community, paving the way for future breakthroughs in the treatment of ocular diseases.